Kirby Wm
About
In The Last Decade
Kirby Wm
18 papers receiving 293 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 190
- Molecular Medicine 107
- Molecular Biology 67
- Infectious Diseases 65
- Epidemiology 48
Countries citing papers authored by Kirby Wm
This map shows the geographic impact of Kirby Wm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirby Wm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirby Wm more than expected).
Fields of papers citing papers by Kirby Wm
This network shows the impact of papers produced by Kirby Wm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirby Wm. The network helps show where Kirby Wm may publish in the future.
Co-authorship network of co-authors of Kirby Wm
This figure shows the co-authorship network connecting the top 25 collaborators of Kirby Wm. A scholar is included among the top collaborators of Kirby Wm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirby Wm. Kirby Wm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Susceptibility of microorganisms to antibiotics isolated from hospitalized and nonhospitalized persons; panel discussion. | 0 |
| 2 | Clinical usefulness of a single disc method for antibiotic sensitivity testing. | 67 |
| 3 | Present status of vancomycin therapy of staphylococcal and streptococcal infections. | 0 |
| 4 | The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion. | 2 |
| 5 | Clinical and laboratory studies of erythromycin propionate. | 0 |
| 6 | Single disc versus multiple disc and plate dilution techniques for antibiotic sensitivity testing. | 19 |
| 7 | Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. | 53 |
| 8 | Clinical pharmacology of pivampicillin as compared with ampicillin. | 33 |
| 9 | Clinical pharmacology of cephalexin administered intravenously. | 4 |
| 10 | Laboratory and clinical studies of carbenicillin against gram-negative bacilli. | 42 |
| 11 | Round table: optimal duration of antibiotic therapy in severe bacterial infections. | 5 |
| 12 | Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration. | 23 |
| 13 | Comparative serum binding of four tetracyclines under simulated in vivo conditions. | 8 |
| 14 | Round table: are new antibiotics needed? | 12 |
| 15 | A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins. | 41 |
| 16 | IMPACT OF THE NEW DRUG REGULATIONS ON TEACHING AND RESEARCH IN MEDICAL SCHOOLS. | 1 |
| 17 | DICLOXACILLIN, A NEW ANTIBIOTIC: CLINICAL STUDIES AND LABORATORY COMPARISONS WITH OXACILLIN AND CLOXACILLIN. | 13 |
| 18 | LABORATORY AND CLINICAL STUDIES OF GENTAMICIN. | 10 |
| 19 | Erythromycin stearate and propionyl erythromycin: a comparison of blood levels obtained after oral administration. | 9 |
| 20 | Triacetyloleandomycin and erythromycin: a comparison of in vitro activity and of blood levels obtained after oral administration. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.